{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Lippincott's Bone and Joint Newsletter, Volume 21, Number 11

Activity Steps

Description

Method of Participation in the Learning Process/Evaluation Method

Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form.

Getting the Most out of the Activity

As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed.

While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Evaluate whether tofacitinib may be a treatment option for their patients with rheumatoid arthritis.
  2. Assess whether the study findings might be useful in talking with their patients about factors associated with pregnancy that may influence the development of postmenopausal osteoporosis.
Price: $49.00

Credits:

  • ACCME 1.5 CME

Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Professions: Physician
Test Code: BJL1215
Published: December 2015
Expires: 1/1/2026
Required Passing Score: 7/10 (70%)
Authors: Ellen Hoffmeister
Categories: Orthopedic , Surgical
Specialties: Orthopedics